EuroEspes S.A (EEP) | Stock Overview & Key Data
EuroEspes S.A. | Small-cap | Healthcare
EuroEspes S.A. | Small-cap | Healthcare
EuroEspes S.A Performance Comparison
Stock Range
Today's Range
Low: €0.54
High: €0.54
on August 8, 2025
52 Week Range
Low: €0.54
High: €0.54
on August 8, 2025
on August 8, 2025
All-Time High: €2.45 on January 20, 2014
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Market Cap
€6.3M
EPS
N/A
P/E Ratio (TTM)
N/A
Forward P/E
N/A
P/B Ratio
N/A
PEG Ratio
N/A
Div. Yield
N/A
ROE
-73.83%
Beta
N/A
Debt to Equity
0.70
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-64.77%
Profit Margin
91.78%
Returns and Earnings
Return on Assets (TTM)
-26.90%
Return on Equity (TTM)
-73.83%
EBITDA
€0
Net Income (TTM)
€-2.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.25
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| EuroEspes S.A EEP | 6.26M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.85% | 35.00% |
| Clinica Baviera S.A CBAV | 698.18M Mid-cap | -1.13% | 0.69% | 17.69% | 25.43% | 39.37% | 52.96% | 113.11% | 393.26% |
| Pangaea Oncology PANG | 58.72M Small-cap | 0.00% | 1.78% | 1.18% | -1.71% | -2.82% | 17.01% | 17.81% | 59.26% |
| Grifols, S.A GRF | 7.81B Large-cap | 0.15% | 19.91% | 58.70% | 53.07% | 36.89% | 47.66% | -5.89% | -47.14% |
| Laboratorios ROVI | 2.75B Large-cap | 1.13% | -2.45% | 1.99% | -2.71% | -16.02% | -29.88% | 4.78% | 92.65% |
| Almirall S.A ALM | 2.20B Large-cap | 0.59% | -4.81% | 3.10% | 13.19% | 22.91% | 14.70% | 4.89% | 7.74% |
Ownership & Short Interest
Insider Ownership
N/A
Institutional Ownership
N/A
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
28
Average 90-Day Volume
3
EuroEspes S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in EuroEspes S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EEP's 52-week high and low?
- In the last 52 weeks, EuroEspes S.A reached a high of €0.54 (on August 8, 2025) and a low of €0.54 (on August 8, 2025).
- What is the market cap and P/E ratio for EEP?
- Curious about EuroEspes S.A's size and valuation? Its market capitalization stands at 6.26M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does EEP pay dividends? If so, what's the yield?
- As for dividends, EuroEspes S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are EuroEspes S.A's main competitors or similar companies to consider before investing?
When looking at EuroEspes S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Clinica Baviera S.A
CBAV698.18M Healthcare Diagnostics & Research 52.96% 113.11% Pangaea Oncology
PANG58.72M Healthcare Diagnostics & Research 17.01% 17.81% Grifols, S.A
GRF7.81B Healthcare Drug Manufacturers - General 47.66% -5.89% Laboratorios
ROVI2.75B Healthcare Drug Manufacturers - Specialty & Generic -29.88% 4.78% Almirall S.A
ALM2.20B Healthcare Drug Manufacturers - Specialty & Generic 14.70% 4.89% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for EuroEspes S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of EuroEspes S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -73.83%, the Debt to Equity ratio from the most recent quarter is 0.70, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for EEP?
- Looking at EuroEspes S.A's growth, its revenue over the trailing twelve months (TTM) was €3M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of EEP stock is held by insiders and institutions?
- Wondering who owns EuroEspes S.A stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.